Sonographic Hysterosalpingography: Oil vs Water Based Media (SHOW Trial)
NCT03604549 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 58
Last updated 2022-05-02
Summary
Performing fluoroscopic HSG with oil based contrast medium has been shown to increase pregnancy rates in a subfertile population. This is a pilot study to test the efficacy of as well as the tolerability and safety of using lipid based oil medium for sonographic based hysterosalpingography (Sono HSG) compared to water based contrast (i.e. normal saline) for women seeking fertility. The double blind study will randomize 56 women at the time of Sono HSG in a 1:1 ratio to receive through the SHG catheter either up to 10 cc of Lipiodol UF® or normal saline. The investigators will collect subjective pain experience and follow the subjects for 6 months after the test for pregnancy and collect all adverse events during and after the procedure.
Conditions
Interventions
- DRUG
-
Lipiodol UF
Up to 10cc of Lipiodol Ultra Fluid will be infused via intrauterine catheter
- DRUG
-
Saline
Up to 10cc of saline will be infused via intrauterine catheter
Sponsors & Collaborators
-
Guerbet
collaborator INDUSTRY -
Milton S. Hershey Medical Center
lead OTHER
Principal Investigators
-
Richard Legro, M.D. · Penn State University and Milton S. Hershey Medical Center
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 40 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-01-11
- Primary Completion
- 2021-05-31
- Completion
- 2021-08-25
- FDA Drug
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Endometrial Shedding Prior to Ovulation Induction Pilot Study
NCT02340013 ·Status: COMPLETED ·Phase: PHASE4
-
Dydrogesterone Versus GnRH Antagonist in Poor Responders Undergoing Double Ovarian Stimulation
NCT06212102 ·Status: RECRUITING ·Phase: PHASE2
-
Routine Hysteroscopy in IVF/ICSI Cycles in Patients With Primary Unexplained Infertility
NCT02416596 ·Status: UNKNOWN ·Phase: NA
-
Uterine Flushing With Human Chorionic Gonadotrophin and Unexplained Infertility
NCT03461601 ·Status: COMPLETED ·Phase: NA
-
Predictors of Ovarian Reserve in Infertile Women
NCT02896023 ·Status: UNKNOWN ·Phase: PHASE4
-
A Multicenter Study Comparing the Efficacy, Safety and Tolerability of Oral Dydrogesterone 30 mg Daily Versus Intravaginal Micronized Progesterone Capsules 600 mg Daily for Luteal Support in In-Vitro Fertilization
NCT01850030 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of a Higher Than Maximum 450IU Gonadotropin Dose in an In-vitro Fertilization Cycle
NCT00971152 ·Status: COMPLETED ·Phase: PHASE3
-
Two Different Types of Luteal Phase Support in Natural Cycle Frozen Embryo Transfer and Its Effect on Pregnancy Rates
NCT05838105 ·Status: UNKNOWN ·Phase: NA
-
Comparison of Live Birth Rate in Natural Cycle Single Euploid FET Versus Without Luteal Phase Support
NCT05969795 ·Status: RECRUITING ·Phase: PHASE1
-
Progesterone Levels During Ovulation and Luteal Phase
NCT05076981 ·Status: COMPLETED
-
Gonadotrophin Dosage Using a Threshold Nomogram for Ovulation Induction in WHO Group II Anovulatory Infertility
NCT01250821 ·Status: COMPLETED ·Phase: PHASE4
-
Prospective Observational Study of Peri-implantation Serum hCG Levels
NCT01184469 ·Status: COMPLETED
-
Synchronization of Ovarian Stimulation for in Vitro Fertilization With Follicular Wave Emergence
NCT01668056 ·Status: UNKNOWN ·Phase: NA
-
Study to Assess the Effect of Intrauterine Adminstration of HCG Versus Endometrial Injury by Pipelle
NCT05050747 ·Status: COMPLETED
-
The Value of Addition of Human Menopausal Gonadotropin Drug Following Oocytes Retrieval in IVF Cycles
NCT03209687 ·Status: COMPLETED ·Phase: PHASE4
-
Early Luteal Phase Progesterone Kinetics After hCG-Induced Ovulation in Modified Natural Cycle
NCT07028710 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Evaluate the Interest of the Pre-conceptional Endometrial Immune Profiling to Increase Birth Rates
NCT02262117 ·Status: COMPLETED ·Phase: NA
-
Impact of IVF Hormonal Therapy on Endometrial Receptivity and Endometrial Senescent Cell Pathological Accumulation
NCT06280560 ·Status: RECRUITING
-
Endometrial Scratch Injury in Women With Unexplained Infertility Undergoing IUI
NCT02349750 ·Status: COMPLETED ·Phase: NA
-
Cumulative Pregnancy Rate With Lower and Higher Gonadotropin Dose During IVF Among Poor Responders
NCT05103228 ·Status: COMPLETED ·Phase: NA
-
Endometrial Markers and Response of Endometriosis Patients to Prolonged GnRH Agonist Prior to IVF
NCT00621179 ·Status: COMPLETED ·Phase: PHASE4
-
Administration of Increased Dose of GnRH Antagonist for Coasting for Decreasing the Risk for Ovarian Hyperstimulation Syndrome( OHSS)
NCT01109888 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH) Response to Low Dose Clomiphene Citrate in Normally Menstruating Fertile Women
NCT01340521 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Stimulated Intrauterine Insemination Cycles and Unstimulated Intrauterine Insemination Cycles in Couples With Unexplained Infertility
NCT02461173 ·Status: UNKNOWN ·Phase: PHASE3
-
Efficacy of Corifollitropin Alfa Versus Follitropin Beta in Aged IVF (In-vitro Fertilization) Patients
NCT02466204 ·Status: COMPLETED ·Phase: PHASE4